Literature DB >> 15239263

A resected case of metachronous liver metastasis from lung cancer producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II).

Yukio Oshiro1, Yasutsugu Takada, Tsuyoshi Enomoto, Katashi Fukao, Shigemi Ishikawa, Tatsuo Iijima.   

Abstract

A resected case of huge liver metastasis of hepatoid adenocarcinoma of the lung is described. A 77-year-old man who presented a solitary huge liver tumor was admitted to our hospital. He had undergone right lower lobectomy of the lung for lung cancer one year before. The view of imaging studies was not a typical one of hepatocellular carcinoma. Serum levels of AFP and PIVKA-II were 334,500ng/mL and 3,890mAU/mL, respectively, and the proportion of AFP L3 was 97.9%. It was thought that they were strongly diagnostic for hepatocellular carcinoma. Extended right lobectomy of the liver was performed. Microscopically, it was poorly differentiated adenocarcinoma and diagnosed as liver metastasis from the formerly resected lung cancer. The tumor was composed of cells with both sheet-like growth and tubule formation. The neoplastic cells, in the sheet-like growth resembled hepatocellular carcinoma cells. By immunohistochemical staining with anti-AFP and anti-PIVKA-II antibodies, cancer cells of both the primary and metastatic lesions were positive. The patient eventually died of multiple liver and bone metastasis 6 months after the operation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15239263

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  14 in total

1.  AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues.

Authors:  Lin Wang; Juxiang Huang; Minghu Jiang; Xiguang Zheng
Journal:  Tumour Biol       Date:  2010-06-08

2.  Primary hepatocellular carcinoma detected long after tumor markers and lymph node metastases--beyond our vision?

Authors:  Jee-Fu Huang; Kenichi Takayasu; Shuichi Okada; Kazuaki Shimada; Yukihiro Nakanishi; Masafumi Ikeda
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

3.  Protein induced by vitamin K absence or antagonist II-producing gastric cancer.

Authors:  Yoshihisa Takahashi; Tohru Inoue; Toshio Fukusato
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

Review 4.  Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.

Authors:  Jia-Xi Mao; Cong Liu; Yuan-Yu Zhao; Guo-Shan Ding; Ji-Qing Ma; Fei Teng; Wen-Yuan Guo
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

5.  Hepatoid carcinoma of the pancreas producing protein induced by vitamin K absence or antagonist II (PIVKA-II) and alpha-fetoprotein (AFP).

Authors:  Kazuhiro Matsueda; Hiroshi Yamamoto; Yasuo Yoshida; Kenji Notohara
Journal:  J Gastroenterol       Date:  2006-11-09       Impact factor: 6.772

6.  Assessment of Serum Tumor Markers for Predicting Ocular Metastasis in Lung Adenocarcinoma: A Retrospective Study.

Authors:  Wen-Qing Shi; Wen-Feng Liu; Biao Li; Qi Lin; Qing-Hai Li; Yu-Qing Zhang; Qing Yuan; Rong-Bin Liang; Qian-Min Ge; Yi Shao
Journal:  Dis Markers       Date:  2020-06-25       Impact factor: 3.434

Review 7.  Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.

Authors:  Kun Yang; Huifeng Jiang; Qiuyao Li
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

8.  Soft-Tissue Localization of Hepatoid Adenocarcinoma: First Case Report.

Authors:  Francesca Fornasa
Journal:  Case Rep Oncol       Date:  2010-07-03

9.  Pulmonary hepatoid adenocarcinoma: report of a case.

Authors:  Yamato Motooka; Kentaro Yoshimoto; Takashi Semba; Koei Ikeda; Takeshi Mori; Yumi Honda; Ken-Ichi Iyama; Makoto Suzuki
Journal:  Surg Case Rep       Date:  2016-01-08

10.  Ocular Metastasis in Elderly Lung Cancer Patients: Potential Risk Factors of CA-125, CA-153 and TPSA.

Authors:  Qian-Min Ge; Yu-Ting Zou; Wen-Qing Shi; Yu-Qing Zhang; Biao Li; You-Lan Min; Qing Yuan; Yi Shao
Journal:  Cancer Manag Res       Date:  2020-03-10       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.